Loading quotes...

Forecast

There is no analyst data available for this company.

News Go to news feed

H&R raises half-year revenue to EUR 700.4 million and EBITDA sharply to EUR 84.4 million

H&R reports revenue of EUR 700.4 million and preliminary EBITDA of EUR 84.4 million for H1 2026 (H1 2025: EUR 40.1 million), driven mainly by the ChemPharm Refining segment. In Q2 EBITDA rose to EUR 62.5 million; the group result attributable to shareholders amounted to EUR 41.6 million for the half-year and earnings per share were EUR 1.12. Operating cash flow and free cash flow were negative in the quarter and the half-year respectively, while the equity ratio remained stable at 45.6%. Management expects to exceed the upper end of the original full-year EBITDA guidance and will further specify expectations; the half-year report will follow on 14 August 2026. » More on finanzen.net
H&R publishes preliminary Q1 2026 figures: revenue down, earnings improved

H&R reports a slightly lower EBITDA for Q1 2026 of EUR 21.9m (Q1/2025: 22.4m) on revenues of EUR 300.2m (Q1/2025: 345.8m). EBIT rose to EUR 9.5m, EBT to EUR 6.7m and profit attributable to shareholders to EUR 3.9m (Q1/2025: 1.9m); earnings per share recovered to EUR 0.10. Operating cash flow improved to EUR 24.9m, free cash flow to EUR 12.9m. By segment, ChemPharm Refining showed a marked improvement, while ChemPharm Sales and the plastics segment remained weaker. H&R confirms the full-year guidance of EUR 85.0–100.0m but points to risks from the situation in the Persian Gulf and higher raw material costs. » More on finanzen.net
H&R posts EBITDA 2025 above forecast but closes full year with loss

H&R reports preliminary EBITDA of EUR 83.8m for 2025, above its internal forecast but below last year’s level. Impairments in refining led to significantly higher write-downs, pushing EBIT to EUR -14.4m and the group net loss to EUR -38.8m. Revenue fell 7.2% to EUR 1,242.2m, while operating cash flow rose to EUR 92.1m and free cash flow to EUR 35.4m. A full presentation will appear in the 2025 annual report on 31 March 2026. » More on de.investing.com

Historical dividends Dividends

All dividend metrics All metrics

In 2025, H&R GmbH & Co has already paid €0.10 in dividends. The last payout was in May 2025.

Financials

In the last quarter, H&R GmbH & Co had revenue of €408.33m and net profit of €37.72m

(EUR)	June 2026	YoY
Revenue	408.33m	32.88%
Gross profit	129.57m	72.71%
Net profit	37.72m	2,410.97%
EBITDA	62.39m	249.08%

Fundamentals

Metric	Value
Market capitalization	€247.9m
Number of shares	37.22m
52-week high/low	€7.60 - €3.91
Dividends	No
Beta	0.42
P/E ratio	111.00
PEG ratio	-0.10
P/B ratio	0.58
P/S ratio	0.19

Company profile

H&R GmbH & Co. KGaA manufactures and sells chemical-pharmaceutical raw materials and injection molded precision plastic parts. It operates through three segments: ChemPharm Refining, ChemPharm Sales, and Plastics. The ChemPharm Refining segment manufactures and distributes paraffins, white oils, plasticizers, base oils, lubricants, and other crude oil-based specialty products, as well as feedstocks and bunker fuels. The ChemPharm Sales segment processes and distributes plasticizers, wax emulsions, paraffins, and other crude oil-based specialty products. The Plastics segment develops, manufactures, and sells precision plastic parts for medical technology, automotive, and other industries. The company also provides petroleum jellies, motor oils, process oils, cable filling compounds, ozone protection waxes, cosmetic and pharmaceutical raw materials, mineral oils, and construction insulation materials. The company was formerly known as H&R Aktiengesellschaft and changed its name to H&R GmbH & Co. KGaA in August 2016. The company was founded in 1919 and is headquartered in Salzbergen, Germany. H&R GmbH & Co. KGaA is a subsidiary of H&R Komplementär GmbH.